definitely undecided.
Is this exercise the best return for shareholders?
Will we be "Throwing good money after bad".
Definitions:
"incur further loss in a hopeless attempt to recoup a previous loss."
"to waste money by spending more money on something you have already spent money on that is no good.."
After 3yrs+.. Why is GeneType not selling?
Has the case plan been put forward well enough for shareholders to throw more funds into the ring.
.
definitely undecided.Is this exercise the best return for...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add GTG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.671M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 25758 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 106032 | 1 |
View Market Depth
| Last trade - 16.12pm 18/10/2024 (20 minute delay) ? |
| GTG (ASX) Chart |
Day chart unavailable